文献速递前列腺增生与排尿功能障碍

基于网络的决策辅助工具对良性前列腺增生所致下尿路症状男性的有效性

Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.
PubMed 文献 · BJU Int · 2019-03-04

该前瞻性问卷研究纳入109例使用决策辅助工具(DA)的患者和108例对照,评估DA对治疗决策质量的影响。结果显示DA组做出知情且价值一致决策的比例更高(43% vs 21%,P=0.028),决策冲突更低,被动决策角色更少,过程后悔更少。结论提示DA可能改善决策质量,建议进一步在常规护理中实施。

要点

  • DA组知情且价值一致决策比例43%,对照组21%(P=0.028)。
  • DA组决策冲突评分33.2,对照组46.6(P=0.003)。
  • DA组被动决策角色比例22%,对照组41%(P=0.038)。

核心结论

  • LUTS/BPH决策辅助工具似乎通过支持患者做出更知情且价值一致的治疗决策来改善决策质量。
  • 建议进一步将该决策辅助工具纳入常规护理。

研究设计与样本

  • 前瞻性问卷研究,2016年7月至2017年1月邀请所有新发LUTS/BPH就诊患者使用DA并参与研究。

主要发现

  • DA组知情且价值一致决策比例43%,对照组21%(P=0.028)。
  • DA组决策冲突评分33.2,对照组46.6(P=0.003)。
  • DA组被动决策角色比例22%,对照组41%(P=0.038)。
  • DA组过程后悔评分2.4,对照组2.8(P=0.034)。
  • 未使用过既往药物的DA使用者选择生活方式建议的比例43%,对照组11%(P=0.002)。

关键数值与推荐

  • 知情决策通过知识问卷测量,价值一致决策通过9项价值陈述与所选治疗的对应关系测量。
  • 主要结局决策质量定义为知情决策与价值一致决策的组合。

临床怎么用

  • 可考虑将基于网络的决策辅助工具用于LUTS/BPH患者的治疗决策支持。
  • 使用DA可能减少决策冲突、被动决策角色和过程后悔。

局限性

  • DA使用者较对照组年轻(68.4 vs 71.5岁;P=0.003)且教育水平更高(P=0.047)。
  • 结果为观察性比较,已对显著不同的基线特征进行调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the effectiveness of a web-based decision aid (DA), with values clarification exercises compared with usual care, for men with lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). PATIENTS AND METHODS: Between July 2016 and January 2017, all new patients with LUTS/BPH who consulted the urologist were invited to use the DA and participate in this prospective questionnaire study. Patients who consulted the urologist between December 2015 and February 2016 served as controls. The DA was designed to support patients in making a well-informed treatment decision, corresponding with their personal preferences and values. Well-informed decision was measured by using a knowledge questionnaire. Value congruent decision was measured by the correspondence between responses on nine value statements and chosen treatment. The primary outcome, decision quality, was defined as the combination of well-informed decision and value congruent decision. Secondary outcomes were decisional conflict, involvement and received role in shared decision-making, decisional regret, and treatment choice. RESULTS: A total of 109 DA-users and 108 controls were included. DA-users were younger (68.4 vs 71.5 years; P = 0.003) and their education level was higher (P = 0.047) compared with the controls. Patients who used the DA made a well-informed and value congruent decision more often than the control group (43% vs 21%; P = 0.028). DA-users had less decisional conflict (score 33.2 vs 46.6; P = 0.003), experienced a less passive role in decision-making (22% vs 41%; P = 0.038), and reported less process regret (score 2.4 vs 2.8; P = 0.034). Furthermore, DA-users who had not used prior medication chose lifestyle advices more often than the control group (43% vs 11%; P = 0.002). Outcomes were adjusted for significantly different baseline characteristics. CONCLUSION: The LUTS/BPH DA seems to improve the decision quality by supporting patients in making more well-informed and value congruent treatment decisions. Therefore, further implementation of this DA into routine care is suggested.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. van der Wijden FC, de Angst IB, Lamers RED, et al. Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2019. PMID: 30589205. doi:10.1111/bju.14646

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。